In an earlier article, we ran the numbers and found that a 22-year-old investor with $20,000 could surpass the million-dollar mark by the time he or she reached age 62. Provided this portfolio only slightly outperformed the market's historical average and returned an annualized 11%, that growth would occur without having our hypothetical investor kick in a single additional penny.
Sure, but what if you're not 22 anymore? Not to worry: Even if you're older -- 42, say, rather than 22 -- and looking to play catch-up without that kind of money in the bank, you, too, can be a millionaire. Really.
Make a commitment
The first step is to commit to investing in the stock market systematically. Do everything you can to make it a no-brainer. After all, if you have to think each month about whether to send money to a brokerage account, chances are -- as with flossing your teeth or eating leafy green vegetables -- you'll opt to take a pass, at least on occasion.
My advice? Just don't do it.
With automatic investing, that's not even an option, which is one reason why participating in your employer's retirement plan is such a smart and Foolish move: The money comes out of your check before it hits your bank account, so you don't even have a chance to miss it.
Similarly, these days, fund companies make it as easy as pie to "dollar-cost average" into their funds. Dollar-cost averaging is just another name for automatic investing, and provided you've picked the right investment vehicle, letting your brokerage or fund company do all the work for you is the very definition of convenient.
After you've made the all-important decision to invest on a regular basis, picking the right investments is the critical next step. Should you opt for growth stocks such as Genentech (NYSE: DNA ) , Medtronic (NYSE: MDT ) , and Qualcomm (Nasdaq: QCOM ) , each of which sports juicy earnings-growth estimates and -- surprise, surprise -- S&P-beating price-to-earnings (P/E) ratios as well? Teva Pharmaceutical (Nasdaq: TEVA ) , Baxter International (NYSE: BAX ) , and PDL BioPharma (Nasdaq: PDLI ) continue to fit that bill, too.
On the other hand, maybe seemingly discounted fare such as UnitedHealth Group (NYSE: UNH ) -- a stock that currently clocks in with a below-market and below-industry P/E of roughly 6 -- is more your style. Another option might be a portfolio of funds that includes a dirt cheap index tracker like the SPDRs (SPY) exchange-traded fund and a clutch of actively managed overachievers.
As the Fool's resident fund geek, I'm a big fan of that last approach, but no matter which path you settle on, the important point is this: Get going now. A 42-year-old who starts from scratch and kicks in $500 a month (and earns the same 11% we hypothesized above) will have more than $380,000 when he or she hits 62.
And obviously, the more, the merrier: Sock away $15,500 each year in your company's 401(k) -- your contribution limit for the 2008 tax year -- and fund an IRA to the tune of four grand a year, and voila! At 11% annualized, your nest egg will grow to more than $1.2 million in 20 years.
The Foolish bottom line
As I suggested in my earlier write-up, time really can be on your side if you invest intelligently. On that front, the Fool has plenty of ideas, and we've collected eight of them into a compact set-and-forget portfolio for our Ready-Made Millionaire service.
RMM will open to new members early next week. Between now and then, we invite you to learn more about the service -- whose real-money portfolio includes stocks, funds and a high-octane ETF -- by clicking here. You can snag a free copy of our 11-Minute Millionaire special report, too, and we'll be sure to let you know when the doors swing open for RMM. Convenient, no?
This article was originally published on Oct. 5, 2006. It has been updated.
Shannon Zimmerman runs point on the Fool's Ready-Made Millionaire service. At the time of publication, Shannon didn't own any of the securities mentioned above. UnitedHealth Group is both an Inside Value and Stock Advisor recommendation. The Fool owns shares of SPDRs and UnitedHealth Group. You can check out the Fool's strict disclosure policy right here.